The most frequent alterations are detected in codon 12 (∼82% of all reported KRAS mutations) and in codon 13 (∼17%), which are both in exon 2 of the KRAS gene [2] and appear to play a major role in the progression of CRC [3]. Here, KRAS is linked to colorectal carcinoma.